u/mei_cardoso

Are you asking about the compound, the weight loss, or both?

Special authorization is a documented exception process with published criteria. Applications that answer those criteria explicitly, point by point, fare better than general clinical narratives.

Small fix — that formulary position is another province’s and does not apply here.

I would not draw a trend line through that. Two points and a gap is not a series.

Has this been raised with whoever prescribes?

GP said no in the spring, specialist said yes eighteen months later.

Adding the practical bit — ask what happens at discharge before you start, not after.

Disagree — that is your province’s formulary position and it does not carry to another.

Where a supplier has no independent testing on file, that is a statement about the evidence and not about their conduct. Saying it the second way is how this board would stop being useful.

this board exists so the failures are on the record too

Not convinced by the attribution. That pattern tracks the cycle in your own log more closely than it tracks the dose.

Marketing authorisation is granted centrally for these products; reimbursement, pricing and prescribing criteria are national competences. Those are decided by different bodies with different processes.

Yes — four nations, four pathways, and threads that ignore that give people the wrong answer confidently.

BMI thresholds vary by ICB and by year

log it while it is fresh, memory tidies things up

inter-lab variance runs a point or two, plan your outrage accordingly

Where in the cycle does this fall, if you are tracking it?

The directory deliberately separates "we have nothing on this name" from "this went badly". Collapsing the two is how boards like this generate false certainty.

That is a report count, not a test count, and it changes how thin the evidence base actually is.

Agreed. Dates and documents make a report. Adjectives make a thread.

What did the referral letter actually say?

Agreed — and keeping the letters with dates is what makes any later challenge possible.

the same product has different names and pack sizes across the union

Confused a rejected claim with a denied authorization for a month and pursued entirely the wrong process.

say the province or the answers will be wrong

Small fix — that formulary position is another province’s and does not apply here.

Criteria changed at plan renewal and the denial that had been immovable simply did not apply any more.

Agreed — write the application against the published criteria rather than around them.

Now I buy small from anyone new, test it, and only then commit. It has cost me a few small orders and saved me one large one.

Chain of custody is why member-funded testing is worth more than a supplied certificate: the vial tested is the vial that arrived at a member’s door.

FGP came back 98.9% on a claimed 98.0%, which is agreement not a discrepancy

Nearly paid a cloned storefront. Caught it because one character in the domain was wrong and I paste rather than type.

Disagree that this is a discrepancy.

yara_bakken is right that the band matters more than the peak. Consistency across lots is the finding.

Cloned storefronts copy assets, layout and testimonial text.

rania_diallo has the group-buy risk right — it is structural, not a judgement about anybody in particular.

Lost money once, years ago, to a shop that pushed hard for a decision the same day. Every time I see that pressure now I close the tab.

check the domain character by character before you check anything else

a domain registered last month with a decade of testimonials is the whole tell

Agreed. Dates and documents make a report. Adjectives make a thread.

This. Anything urging you to decide today is doing so for its own reasons.